624 related articles for article (PubMed ID: 31655559)
1. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract][Full Text] [Related]
2. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
[TBL] [Abstract][Full Text] [Related]
3. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
[TBL] [Abstract][Full Text] [Related]
4. Development and clinical application of an integrative genomic approach to personalized cancer therapy.
Uzilov AV; Ding W; Fink MY; Antipin Y; Brohl AS; Davis C; Lau CY; Pandya C; Shah H; Kasai Y; Powell J; Micchelli M; Castellanos R; Zhang Z; Linderman M; Kinoshita Y; Zweig M; Raustad K; Cheung K; Castillo D; Wooten M; Bourzgui I; Newman LC; Deikus G; Mathew B; Zhu J; Glicksberg BS; Moe AS; Liao J; Edelmann L; Dudley JT; Maki RG; Kasarskis A; Holcombe RF; Mahajan M; Hao K; Reva B; Longtine J; Starcevic D; Sebra R; Donovan MJ; Li S; Schadt EE; Chen R
Genome Med; 2016 Jun; 8(1):62. PubMed ID: 27245685
[TBL] [Abstract][Full Text] [Related]
5. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.
Atak ZK; Gianfelici V; Hulselmans G; De Keersmaecker K; Devasia AG; Geerdens E; Mentens N; Chiaretti S; Durinck K; Uyttebroeck A; Vandenberghe P; Wlodarska I; Cloos J; Foà R; Speleman F; Cools J; Aerts S
PLoS Genet; 2013; 9(12):e1003997. PubMed ID: 24367274
[TBL] [Abstract][Full Text] [Related]
7. Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.
Xu C; Nikolova O; Basom RS; Mitchell RM; Shaw R; Moser RD; Park H; Gurley KE; Kao MC; Green CL; Schaub FX; Diaz RL; Swan HA; Jang IS; Guinney J; Gadi VK; Margolin AA; Grandori C; Kemp CJ; Méndez E
Clin Cancer Res; 2018 Jun; 24(12):2828-2843. PubMed ID: 29599409
[No Abstract] [Full Text] [Related]
8. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
[TBL] [Abstract][Full Text] [Related]
10. Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics.
Kumar A; Drusbosky LM; Meacham A; Turcotte M; Bhargav P; Vasista S; Usmani S; Pampana A; Basu K; Tyagi A; Lala D; Rajagopalan S; Birajdar SC; Alam A; Ghosh Roy K; Abbasi T; Vali S; Sengar M; Chinnaswamy G; Shah BD; Cogle CR
Leuk Res; 2019 Mar; 78():3-11. PubMed ID: 30641417
[TBL] [Abstract][Full Text] [Related]
11. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.
Bentley VL; Veinotte CJ; Corkery DP; Pinder JB; LeBlanc MA; Bedard K; Weng AP; Berman JN; Dellaire G
Haematologica; 2015 Jan; 100(1):70-6. PubMed ID: 25281505
[TBL] [Abstract][Full Text] [Related]
12. An Overview of DNA Analytical Methods.
Arboleda VA; Xian RR
Methods Mol Biol; 2019; 1897():385-402. PubMed ID: 30539459
[TBL] [Abstract][Full Text] [Related]
13. In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome.
Piñeiro-Yáñez E; Jiménez-Santos MJ; Gómez-López G; Al-Shahrour F
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540260
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.
Malgerud L; Lindberg J; Wirta V; Gustafsson-Liljefors M; Karimi M; Moro CF; Stecker K; Picker A; Huelsewig C; Stein M; Bohnert R; Del Chiaro M; Haas SL; Heuchel RL; Permert J; Maeurer MJ; Brock S; Verbeke CS; Engstrand L; Jackson DB; Grönberg H; Löhr JM
Mol Oncol; 2017 Oct; 11(10):1413-1429. PubMed ID: 28675654
[TBL] [Abstract][Full Text] [Related]
15. PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data.
Jiménez-Santos MJ; Nogueira-Rodríguez A; Piñeiro-Yáñez E; López-Fernández H; García-Martín S; Gómez-Plana P; Reboiro-Jato M; Gómez-López G; Glez-Peña D; Al-Shahrour F
Nucleic Acids Res; 2023 Jul; 51(W1):W411-W418. PubMed ID: 37207338
[TBL] [Abstract][Full Text] [Related]
16. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
[TBL] [Abstract][Full Text] [Related]
17. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
18. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
19. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
20. GMIEC: a shiny application for the identification of gene-targeted drugs for precision medicine.
Malagoli Tagliazucchi G; Taccioli C
BMC Genomics; 2020 Sep; 21(1):619. PubMed ID: 32912170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
